Facebook Linkedin Twitter
Inside Precision Medicine CMS Proposes Coverage for Thermo Fisher Scientific NSCLC Diagnostic

Health care economics

Ironman-Boxes-PGM-Dx-30Apr2017
Molecular Dx

CMS Proposes Coverage for Thermo Fisher Scientific NSCLC Diagnostic

Alex Philippidis
0
Genomic Health's Oncotype DX Genomic Prostate Score (GPS) test will be evaluated for the prostate cancer drug pipeline of Johnson & Johnson’s Janssen Pharmaceuticals through a research collaboration. [Source: National Cancer Institute
Molecular Dx

Janssen to Use Genomic Health Test in Prostate Cancer Collaboration

0
Genetic testing concept, DNA icon, medical doctor, isolated on white
News & Features

Anthem, UnitedHealthcare Move toward Quicker Prior Authorizations for Some Tests

Alex Philippidis
0
Proposed 2018 Medicare payment rates for clinical diagnostics
Molecular Dx

Laboratories Take Aim at Proposed PAMA 2018 Medicare Rates for Tests

Alex Philippidis
0
Business teamwork - puzzle pieces
News & Features

Cancer Genetics to Pay $12M for vivoPharm

0
Picture of patient receiving a dancer drug to represent precision cancer therapies
News & Features

ASCO Advocates Value Framework to Combat High Cancer Drug Prices

0
Compliance
Molecular Dx

Theranos, CMS Reach Legal Settlement

0
Cancer Research UK (CRUK) had intended to make only one award this year in its £100 million Grand Challenge research initiative
News & Features

Up for the Challenge: Cancer Research UK Grants £71M to Four Grand Challenge Research Teams

Chris Anderson
0
Seamless DNA background
Molecular Dx

Human Longevity Inks Agreement to Offer Whole Genome Sequencing to MassMutual Customers

0
Source: © WavebreakmediaMicro/Fotolia
News & Features

Congenica Plans Further Platform Growth with $10M in Series B Financing

0
1...23242526Page 24 of 26

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine